Turning Point Therapeutics and EQRx Announce Clinical Collaboration to Evaluate Elzovantinib in Combination with Aumolertinib…
Arboretum_JDOctober 14, 2021
News
Success Begins Here
Dive into our most recent firm and portfolio updates
Delphinus Medical Technologies, Inc. today announced that the U.S. Food and Drug Administration (FDA) has…
Arboretum_JDOctober 12, 2021
Interim clinical trial data presented at American Vein and Lymphatic Society Annual Congress demonstrate patient…
Arboretum_JDOctober 11, 2021
EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines…
Arboretum_JDOctober 7, 2021
Jan joins Andrew Cleeland, CEO of Fogarty Innovation and shares insights behind her successful career.
Arboretum_JDOctober 7, 2021
Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through…
Arboretum_JDSeptember 29, 2021
In this episode, Giovanni and Tom discuss founding and managing a midwestern fund, the relationships…
Arboretum_JDSeptember 23, 2021
Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology,…
Arboretum_JDSeptember 16, 2021
Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management…
Arboretum_JDSeptember 15, 2021
